Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 171

1.

Complete Genome Sequences of Bacillus Bacteriophages Wes44 and Carmen17.

Alder H, Himelright M, Eisemann E, Temple L.

Microbiol Resour Announc. 2019 Mar 21;8(12). pii: e01103-18. doi: 10.1128/MRA.01103-18.

2.

Human-like hyperplastic prostate with low ZIP1 induced solely by Zn deficiency in rats.

Fong LY, Jing R, Smalley KJ, Wang ZX, Taccioli C, Fan S, Chen H, Alder H, Huebner K, Farber JL, Fiehn O, Croce CM.

Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11091-E11100. doi: 10.1073/pnas.1813956115. Epub 2018 Nov 5.

3.

Integration of metabolomics, transcriptomics, and microRNA expression profiling reveals a miR-143-HK2-glucose network underlying zinc-deficiency-associated esophageal neoplasia.

Fong LY, Jing R, Smalley KJ, Taccioli C, Fahrmann J, Barupal DK, Alder H, Farber JL, Fiehn O, Croce CM.

Oncotarget. 2017 Jun 9;8(47):81910-81925. doi: 10.18632/oncotarget.18434. eCollection 2017 Oct 10.

4.

Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development.

Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM.

Cancer Cell. 2016 Aug 8;30(2):349-351. doi: 10.1016/j.ccell.2016.07.007. Epub 2016 Aug 8. No abstract available.

5.

MicroRNA dysregulation and esophageal cancer development depend on the extent of zinc dietary deficiency.

Fong LY, Taccioli C, Jing R, Smalley KJ, Alder H, Jiang Y, Fadda P, Farber JL, Croce CM.

Oncotarget. 2016 Mar 8;7(10):10723-38. doi: 10.18632/oncotarget.7561.

6.

A selective screening platform reveals unique global expression patterns of microRNAs in a cohort of human soft-tissue sarcomas.

Yu PY, Balkhi MY, Ladner KJ, Alder H, Yu L, Mo X, Kraybill WG, Guttridge DC, Iwenofu OH.

Lab Invest. 2016 Apr;96(4):481-91. doi: 10.1038/labinvest.2015.168. Epub 2016 Feb 15.

7.

Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo.

Taccioli C, Garofalo M, Chen H, Jiang Y, Tagliazucchi GM, Di Leva G, Alder H, Fadda P, Middleton J, Smalley KJ, Selmi T, Naidu S, Farber JL, Croce CM, Fong LY.

J Natl Cancer Inst. 2015 Aug 18;107(11). pii: djv220. doi: 10.1093/jnci/djv220. Print 2015 Nov.

8.

A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies.

Drusco A, Bottoni A, Laganà A, Acunzo M, Fassan M, Cascione L, Antenucci A, Kumchala P, Vicentini C, Gardiman MP, Alder H, Carosi MA, Ammirati M, Gherardi S, Luscrì M, Carapella C, Zanesi N, Croce CM.

Oncotarget. 2015 Aug 28;6(25):20829-39.

9.

Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.

Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G, Romano G, Crawford M, Nana-Sinkam P, Croce CM.

PLoS One. 2015 Jun 25;10(6):e0131729. doi: 10.1371/journal.pone.0131729. eCollection 2015. No abstract available.

10.

A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in lung cancer.

Jeon YJ, Middleton J, Kim T, Laganà A, Piovan C, Secchiero P, Nuovo GJ, Cui R, Joshi P, Romano G, Di Leva G, Lee BK, Sun HL, Kim Y, Fadda P, Alder H, Garofalo M, Croce CM.

Proc Natl Acad Sci U S A. 2015 Jun 30;112(26):E3355-64. doi: 10.1073/pnas.1504630112. Epub 2015 Jun 15. Erratum in: Proc Natl Acad Sci U S A. 2017 Mar 21;114(12 ):E2542.

11.

MYC-repressed long noncoding RNAs antagonize MYC-induced cell proliferation and cell cycle progression.

Kim T, Cui R, Jeon YJ, Fadda P, Alder H, Croce CM.

Oncotarget. 2015 Aug 7;6(22):18780-9.

12.

Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.

Kim T, Jeon YJ, Cui R, Lee JH, Peng Y, Kim SH, Tili E, Alder H, Croce CM.

J Natl Cancer Inst. 2015 Feb 6;107(4). pii: dju505. doi: 10.1093/jnci/dju505. Print 2015 Apr.

13.

Egg yolks inhibit activation of NF-κB and expression of its target genes in adipocytes after partial delipidation.

Shen Q, Riedl KM, Cole RM, Lehman C, Xu L, Alder H, Belury MA, Schwartz SJ, Ziouzenkova O.

J Agric Food Chem. 2015 Feb 25;63(7):2013-25. doi: 10.1021/jf5056584. Epub 2015 Feb 12.

14.

Pluripotent stem cell miRNAs and metastasis in invasive breast cancer.

Volinia S, Nuovo G, Drusco A, Costinean S, Abujarour R, Desponts C, Garofalo M, Baffa R, Aeqilan R, Maharry K, Sana ME, Di Leva G, Gasparini P, Dama P, Marchesini J, Galasso M, Manfrini M, Zerbinati C, Corrà F, Wise T, Wojcik SE, Previati M, Pichiorri F, Zanesi N, Alder H, Palatini J, Huebner KF, Shapiro CL, Negrini M, Vecchione A, Rosenberg AL, Croce CM, Garzon R.

J Natl Cancer Inst. 2014 Oct 11;106(12). pii: dju324. doi: 10.1093/jnci/dju324. Print 2014 Dec. Erratum in: J Natl Cancer Inst. 2014 Nov:106(11):dju373doi:10.1093/jnci/dju373. Garzon, Maria Elena Sana Ramiro [Corrected to Garzon, Ramiro and Sana, Maria Elena].

15.

Computer-based diagnostic expert systems in rheumatology: where do we stand in 2014?

Alder H, Michel BA, Marx C, Tamborrini G, Langenegger T, Bruehlmann P, Steurer J, Wildi LM.

Int J Rheumatol. 2014;2014:672714. doi: 10.1155/2014/672714. Epub 2014 Jul 8. Review.

16.

MicroRNA profiles discriminate among colon cancer metastasis.

Drusco A, Nuovo GJ, Zanesi N, Di Leva G, Pichiorri F, Volinia S, Fernandez C, Antenucci A, Costinean S, Bottoni A, Rosito IA, Liu CG, Burch A, Acunzo M, Pekarsky Y, Alder H, Ciardi A, Croce CM.

PLoS One. 2014 Jun 12;9(6):e96670. doi: 10.1371/journal.pone.0096670. eCollection 2014.

17.

Circulating miRNA markers show promise as new prognosticators for multiple myeloma.

Rocci A, Hofmeister CC, Geyer S, Stiff A, Gambella M, Cascione L, Guan J, Benson DM, Efebera YA, Talabere T, Dirisala V, Smith EM, Omedè P, Isaia G, De Luca L, Rossi D, Gentili S, Uccello G, Consiglio J, Ria R, Benevolo G, Bringhen S, Callea V, Weiss B, Ferro A, Magarotto V, Alder H, Byrd JC, Boccadoro M, Marcucci G, Palumbo A, Pichiorri F.

Leukemia. 2014 Sep;28(9):1922-6. doi: 10.1038/leu.2014.155. Epub 2014 May 12. No abstract available.

18.

Use of laser capture microdissection for the assessment of equine lamellar basal epithelial cell signalling in the early stages of laminitis.

Leise BS, Watts MR, Roy S, Yilmaz AS, Alder H, Belknap JK.

Equine Vet J. 2015 Jul;47(4):478-88. doi: 10.1111/evj.12283. Epub 2014 Aug 19.

19.

MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer.

Valeri N, Braconi C, Gasparini P, Murgia C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat F, Paone A, Cascione L, Sumani KM, Veronese A, Fabbri M, Carasi S, Alder H, Lanza G, Gafa' R, Moyer MP, Ridgway RA, Cordero J, Nuovo GJ, Frankel WL, Rugge M, Fassan M, Groden J, Vogt PK, Karin M, Sansom OJ, Croce CM.

Cancer Cell. 2014 Apr 14;25(4):469-83. doi: 10.1016/j.ccr.2014.03.006.

20.

Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5.

Kim T, Cui R, Jeon YJ, Lee JH, Lee JH, Sim H, Park JK, Fadda P, Tili E, Nakanishi H, Huh MI, Kim SH, Cho JH, Sung BH, Peng Y, Lee TJ, Luo Z, Sun HL, Wei H, Alder H, Oh JS, Shim KS, Ko SB, Croce CM.

Proc Natl Acad Sci U S A. 2014 Mar 18;111(11):4173-8. doi: 10.1073/pnas.1400350111. Epub 2014 Mar 4.

21.

Aldehyde dehydrogenase-1a1 induces oncogene suppressor genes in B cell populations.

Yasmeen R, Meyers JM, Alvarez CE, Thomas JL, Bonnegarde-Bernard A, Alder H, Papenfuss TL, Benson DM Jr, Boyaka PN, Ziouzenkova O.

Biochim Biophys Acta. 2013 Dec;1833(12):3218-3227. doi: 10.1016/j.bbamcr.2013.09.012. Epub 2013 Sep 27.

22.

A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.

Collins AL, Wojcik S, Liu J, Frankel WL, Alder H, Yu L, Schmittgen TD, Croce CM, Bloomston M.

Ann Surg Oncol. 2014 Jan;21(1):133-8. doi: 10.1245/s10434-013-3240-y. Epub 2013 Sep 18.

23.

MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer.

Garofalo M, Jeon YJ, Nuovo GJ, Middleton J, Secchiero P, Joshi P, Alder H, Nazaryan N, Di Leva G, Romano G, Crawford M, Nana-Sinkam P, Croce CM.

PLoS One. 2013 Jun 21;8(6):e67581. doi: 10.1371/journal.pone.0067581. Print 2013.

24.

Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression.

Galli R, Paone A, Fabbri M, Zanesi N, Calore F, Cascione L, Acunzo M, Stoppacciaro A, Tubaro A, Lovat F, Gasparini P, Fadda P, Alder H, Volinia S, Filippini A, Ziparo E, Riccioli A, Croce CM.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9812-7. doi: 10.1073/pnas.1304610110. Epub 2013 May 28.

25.

A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis.

Vecchione A, Belletti B, Lovat F, Volinia S, Chiappetta G, Giglio S, Sonego M, Cirombella R, Onesti EC, Pellegrini P, Califano D, Pignata S, Losito S, Canzonieri V, Sorio R, Alder H, Wernicke D, Stoppacciaro A, Baldassarre G, Croce CM.

Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9845-50. doi: 10.1073/pnas.1305472110. Epub 2013 May 22.

26.

Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.

Di Leva G, Piovan C, Gasparini P, Ngankeu A, Taccioli C, Briskin D, Cheung DG, Bolon B, Anderlucci L, Alder H, Nuovo G, Li M, Iorio MV, Galasso M, Santhanam R, Marcucci G, Perrotti D, Powell KA, Bratasz A, Garofalo M, Nephew KP, Croce CM.

PLoS Genet. 2013;9(3):e1003311. doi: 10.1371/journal.pgen.1003311. Epub 2013 Mar 7. Erratum in: PLoS Genet. 2013 Apr;9(4). doi:10.1371/annotation/92dfa670-d431-4d68-b70b-706df1f93e46. Ramasamy, Santhanam [corrected to Santhanam, Ramasamy].

27.

Identification of sensitive serum microRNA biomarkers for radiation biodosimetry.

Jacob NK, Cooley JV, Yee TN, Jacob J, Alder H, Wickramasinghe P, Maclean KH, Chakravarti A.

PLoS One. 2013;8(2):e57603. doi: 10.1371/journal.pone.0057603. Epub 2013 Feb 25.

28.

Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer.

Cascione L, Gasparini P, Lovat F, Carasi S, Pulvirenti A, Ferro A, Alder H, He G, Vecchione A, Croce CM, Shapiro CL, Huebner K.

PLoS One. 2013;8(2):e55910. doi: 10.1371/journal.pone.0055910. Epub 2013 Feb 6.

29.

Autocrine function of aldehyde dehydrogenase 1 as a determinant of diet- and sex-specific differences in visceral adiposity.

Yasmeen R, Reichert B, Deiuliis J, Yang F, Lynch A, Meyers J, Sharlach M, Shin S, Volz KS, Green KB, Lee K, Alder H, Duester G, Zechner R, Rajagopalan S, Ziouzenkova O.

Diabetes. 2013 Jan;62(1):124-36. doi: 10.2337/db11-1779. Epub 2012 Aug 28.

30.

Trisomy 12 CLLs progress through NOTCH1 mutations.

Balatti V, Lerner S, Rizzotto L, Rassenti LZ, Bottoni A, Palamarchuk A, Cascione L, Alder H, Keating MJ, Kipps TJ, Pekarsky Y, Croce CM.

Leukemia. 2013 Mar;27(3):740-3. doi: 10.1038/leu.2012.239. Epub 2012 Aug 20. No abstract available.

31.

MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.

Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, Lovat F, Fadda P, Mao C, Nuovo GJ, Zanesi N, Crawford M, Ozer GH, Wernicke D, Alder H, Caligiuri MA, Nana-Sinkam P, Perrotti D, Croce CM.

Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):E2110-6. doi: 10.1073/pnas.1209414109. Epub 2012 Jul 2.

32.

Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer.

Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM, Fong LY.

Carcinogenesis. 2012 Sep;33(9):1736-44. doi: 10.1093/carcin/bgs204. Epub 2012 Jun 10.

33.

MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme.

Suh SS, Yoo JY, Nuovo GJ, Jeon YJ, Kim S, Lee TJ, Kim T, Bakàcs A, Alder H, Kaur B, Aqeilan RI, Pichiorri F, Croce CM.

Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5316-21. doi: 10.1073/pnas.1202465109. Epub 2012 Mar 19.

34.

Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL).

Palamarchuk A, Yan PS, Zanesi N, Wang L, Rodrigues B, Murphy M, Balatti V, Bottoni A, Nazaryan N, Alder H, Rassenti L, Kipps TJ, Freitas M, Croce CM, Pekarsky Y.

Proc Natl Acad Sci U S A. 2012 Feb 14;109(7):2555-60. doi: 10.1073/pnas.1200003109. Epub 2012 Jan 30.

35.

EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers.

Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, Nephew KP, Croce CM.

Nat Med. 2011 Dec 11;18(1):74-82. doi: 10.1038/nm.2577. Erratum in: Nat Med. 2014 Jan;20(1):103.

36.

NOTCH1 mutations in CLL associated with trisomy 12.

Balatti V, Bottoni A, Palamarchuk A, Alder H, Rassenti LZ, Kipps TJ, Pekarsky Y, Croce CM.

Blood. 2012 Jan 12;119(2):329-31. doi: 10.1182/blood-2011-10-386144. Epub 2011 Nov 15.

37.

miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing.

Guerau-de-Arellano M, Alder H, Ozer HG, Lovett-Racke A, Racke MK.

J Neuroimmunol. 2012 Jul 15;248(1-2):32-9. doi: 10.1016/j.jneuroim.2011.10.006. Epub 2011 Nov 9. Review.

38.

IRF4 mutations in chronic lymphocytic leukemia.

Havelange V, Pekarsky Y, Nakamura T, Palamarchuk A, Alder H, Rassenti L, Kipps T, Croce CM.

Blood. 2011 Sep 8;118(10):2827-9. doi: 10.1182/blood-2011-04-350579. Epub 2011 Jul 25.

39.

MicroRNA-375 and MicroRNA-221: Potential Noncoding RNAs Associated with Antiproliferative Activity of Benzyl Isothiocyanate in Pancreatic Cancer.

Basu A, Alder H, Khiyami A, Leahy P, Croce CM, Haldar S.

Genes Cancer. 2011 Feb;2(2):108-19. doi: 10.1177/1947601911409212.

40.

Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation.

Orlovsky K, Kalinkovich A, Rozovskaia T, Shezen E, Itkin T, Alder H, Ozer HG, Carramusa L, Avigdor A, Volinia S, Buchberg A, Mazo A, Kollet O, Largman C, Croce CM, Nakamura T, Lapidot T, Canaani E.

Proc Natl Acad Sci U S A. 2011 May 10;108(19):7956-61. doi: 10.1073/pnas.1103154108. Epub 2011 Apr 25.

41.

p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2.

Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, Croce CM.

J Exp Med. 2011 May 9;208(5):875-83. doi: 10.1084/jem.20110235. Epub 2011 Apr 25.

42.

Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD I.

He H, Liyanarachchi S, Akagi K, Nagy R, Li J, Dietrich RC, Li W, Sebastian N, Wen B, Xin B, Singh J, Yan P, Alder H, Haan E, Wieczorek D, Albrecht B, Puffenberger E, Wang H, Westman JA, Padgett RA, Symer DE, de la Chapelle A.

Science. 2011 Apr 8;332(6026):238-40. doi: 10.1126/science.1200587.

43.

Concerted action of aldehyde dehydrogenases influences depot-specific fat formation.

Reichert B, Yasmeen R, Jeyakumar SM, Yang F, Thomou T, Alder H, Duester G, Maiseyeu A, Mihai G, Harrison EH, Rajagopalan S, Kirkland JL, Ziouzenkova O.

Mol Endocrinol. 2011 May;25(5):799-809. doi: 10.1210/me.2010-0465. Epub 2011 Mar 24.

44.

Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer.

Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, Croce CM.

Proc Natl Acad Sci U S A. 2011 Mar 22;108(12):4908-13. doi: 10.1073/pnas.1101795108. Epub 2011 Mar 7.

45.

Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes.

Sokol L, Caceres G, Volinia S, Alder H, Nuovo GJ, Liu CG, McGraw K, Clark JA, Sigua CA, Chen DT, Moscinski L, Croce CM, List AF.

Br J Haematol. 2011 Apr;153(1):24-32. doi: 10.1111/j.1365-2141.2011.08581.x. Epub 2011 Feb 21.

46.

Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia.

Fabbri M, Bottoni A, Shimizu M, Spizzo R, Nicoloso MS, Rossi S, Barbarotto E, Cimmino A, Adair B, Wojcik SE, Valeri N, Calore F, Sampath D, Fanini F, Vannini I, Musuraca G, Dell'Aquila M, Alder H, Davuluri RV, Rassenti LZ, Negrini M, Nakamura T, Amadori D, Kay NE, Rai KR, Keating MJ, Kipps TJ, Calin GA, Croce CM.

JAMA. 2011 Jan 5;305(1):59-67. doi: 10.1001/jama.2010.1919.

47.

MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2).

Valeri N, Gasparini P, Braconi C, Paone A, Lovat F, Fabbri M, Sumani KM, Alder H, Amadori D, Patel T, Nuovo GJ, Fishel R, Croce CM.

Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21098-103. doi: 10.1073/pnas.1015541107. Epub 2010 Nov 15.

48.

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development.

Pichiorri F, Suh SS, Rocci A, De Luca L, Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder H, Garofalo M, Di Leva G, Volinia S, Lin HJ, Perrotti D, Kuehl M, Aqeilan RI, Palumbo A, Croce CM.

Cancer Cell. 2010 Oct 19;18(4):367-81. doi: 10.1016/j.ccr.2010.09.005. Erratum in: Cancer Cell. 2016 Aug 8;30(2):349-351.

49.

Role of PTPRJ genotype in papillary thyroid carcinoma risk.

Iuliano R, Palmieri D, He H, Iervolino A, Borbone E, Pallante P, Cianflone A, Nagy R, Alder H, Calin GA, Trapasso F, Giordano C, Croce CM, de la Chapelle A, Fusco A.

Endocr Relat Cancer. 2010 Oct 29;17(4):1001-6. doi: 10.1677/ERC-10-0143. Print 2010 Dec.

50.

GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials.

Tili E, Michaille JJ, Liu CG, Alder H, Taccioli C, Volinia S, Calin GA, Croce CM.

Nucleic Acids Res. 2010 Nov;38(21):7673-88. doi: 10.1093/nar/gkq637. Epub 2010 Jul 17.

Supplemental Content

Support Center